+454.2%
MRNA vs CSGP
-66.3%
+520.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CSGP | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -2.5% | -0.9% | -0.9% |
| 7D | -10.1% | -5.4% | -4.7% | -5.1% |
| 30D | +126.7% | -6.0% | +132.8% | +153.6% |
| 3M | +184.1% | -12.8% | +196.9% | +220.8% |
| 6M | +143.3% | -38.9% | +182.2% | +209.7% |
| YTD | +359.9% | -56.0% | +415.9% | +546.4% |
| 1Y | +454.2% | -66.4% | +520.6% | +781.7% |
| All | +454.2% | -66.3% | +520.5% | +781.7% |
Cumulative growth
Daily Returns
Daily percentage return beside CSGP.
Daily Out/Under-Performance
Portfolio return minus CSGP return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CSGP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CSGP wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling